6
Participants
Start Date
April 10, 2019
Primary Completion Date
January 1, 2026
Study Completion Date
January 1, 2026
responsive neurostimulation
The RNS® System is a novel, implantable therapeutic device that delivers responsive neurostimulation, an advanced technology designed to continuously monitor brain electrical activity, detect abnormal electrical activity and respond by delivering imperceptible levels of electrical stimulation to normalize that activity before an individual experiences seizures. This is an Early Feasibility Study determining the safety and efficacy of NAc-RNS in the treatment of LOC eating in treatment-refractory obesity.
University of Pennsylvania, Philadelphia
Stanford University, Stanford
Collaborators (1)
NeuroPace
INDUSTRY
University of Pennsylvania
OTHER